server temporarily unavailable
By Kate Gibson, MarketWatch NEW YORK (MarketWatch) — Shares of the following companies made notable moves in the U.S. stock market Monday:
Oxigene Inc.’s /quotes/zigman/4149096/quotes/nls/oxgn OXGN +7.49% shares rose 7.5% after the biotech company on Saturday reported encouraging data on a potential treatment for non-small-cell lung cancer.
Amedisys Inc.’s /quotes/zigman/58963/quotes/nls/amed AMED -7.41% shares declined 7.4% after CRT Capital Group LLC cut its 2011 earnings estimates for the home-nursing provider.
Exelixis Inc.’s /quotes/zigman/82395/quotes/nls/exel EXEL -20.20% shares tumbled 20% after Canaccord Genuity said data from a trial of the company’s cancer-drug candidate could complicate its regulatory strategy.
Steve Jobs unveils Apple's iCloud online storage service. Plus, the Dow makes it four losses in a row and why the 2012 election will focus on jobs, ABC announces Katie Couric's new daytime talk show and recognizing the warning signs of migraines.
Gen-Probe Inc.’s /quotes/zigman/88003/quotes/nls/gpro GPRO -12.66% shares shed 13% after the Wall Street Journal reported Novartis AG /quotes/zigman/171707/quotes/nls/nvs NVS -0.96% could opt out of making an offer for the medical-test manufacturer.
Lorillard Inc.’s /quotes/zigman/511272/quotes/nls/lo LO -7.27% shares dropped 7.3% after Barron’s wrote that any major curbs on menthol cigarettes would hurt the tobacco firm in the short term.
Merge Healthcare Inc.’s /quotes/zigman/109871/quotes/nls/mrge MRGE -5.83% shares shed 5.8% after the medical-imaging provider said it would acquire Ophthalmic Imaging Systems for $30.3 million in stock.
Southern Copper Corp.’s /quotes/zigman/395341/quotes/nls/scco SCCO -11.35% U.S.-listed shares fell 11%, with the Peruvian metal producer hit after a former army rebel claimed victory in Peru’s presidential runoff. Credicorp Ltd.’s /quotes/zigman/125671/quotes/nls/bap BAP -18.81% U.S. listed shares lapsed 19% after Raymond James Financial Inc. cut the Peruvian financial-services firm to underperform from outperform.
United Therapeutics Corp.’s /quotes/zigman/66427/quotes/nls/uthr UTHR -5.90% shares fell 5.9% as investors offered a less-than-enthusiastic reaction to its release of study results on a potential treatment for high blood pressure.
/quotes/zigman/4149096/quotes/nls/oxgn
/quotes/zigman/58963/quotes/nls/amed
/quotes/zigman/82395/quotes/nls/exel
/quotes/zigman/88003/quotes/nls/gpro
/quotes/zigman/171707/quotes/nls/nvs
/quotes/zigman/511272/quotes/nls/lo
/quotes/zigman/109871/quotes/nls/mrge
/quotes/zigman/395341/quotes/nls/scco
/quotes/zigman/125671/quotes/nls/bap
/quotes/zigman/66427/quotes/nls/uthr
Kate Gibson is a reporter for MarketWatch, based in New York. View the original article here
Nenhum comentário:
Postar um comentário